A detailed history of Investors Research Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Investors Research Corp holds 185 shares of ABT stock, worth $21,785. This represents 0.0% of its overall portfolio holdings.

Number of Shares
185
Previous 185 -0.0%
Holding current value
$21,785
Previous $19,000 10.53%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $6,550 - $7,298
65 Added 54.17%
185 $20,000
Q4 2022

Feb 06, 2023

BUY
$95.06 - $111.52 $9,030 - $10,594
95 Added 380.0%
120 $13,000
Q1 2022

Apr 13, 2022

BUY
$114.02 - $139.04 $2,850 - $3,476
25 New
25 $3,000
Q2 2020

Jul 21, 2020

SELL
$76.57 - $98.0 $19,142 - $24,500
-250 Closed
0 $0
Q2 2019

Jul 08, 2019

SELL
$72.88 - $85.0 $21,864 - $25,500
-300 Reduced 54.55%
250 $21,000
Q1 2019

Apr 23, 2019

BUY
$66.22 - $80.06 $36,421 - $44,033
550 New
550 $44,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Investors Research Corp Portfolio

Follow Investors Research Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

News

Stay updated on Investors Research Corp with notifications on news.